All changes for the tissue nervous system (667)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1283
wingless related MMTV integration site 10a
Molecular
cochlea
Mouse
Wnt10a
16.0% Increase Gene Expression Level
DAA1277
aldo-keto reductase family 1, member C18
Molecular
cochlea
Mouse
Akr1c18
20.0% Decrease Gene Expression Level
DAA1279
phosphopantothenoylcysteine decarboxylase
Molecular
cochlea
Mouse
Ppcdc
6.0% Increase Gene Expression Level
DAA1280
oxytocin receptor
Molecular
cochlea
Mouse
Oxtr
19.0% Increase Gene Expression Level
DAA1282
deleted in malignant brain tumors 1
Molecular
cochlea
Mouse
Dmbt1
1.0% Increase Gene Expression Level
DAA1281
indolethylamine N-methyltransferase
Molecular
cochlea
Mouse
Inmt
6.0% Decrease Gene Expression Level
DAA1278
CD38 antigen
Molecular
cochlea
Mouse
Cd38
26.0% Increase Gene Expression Level
DAA1287
fatty acid binding protein 5, epidermal
Molecular
visual apparatus
Mouse
Fabp5
259.0% Increase Gene Expression Level
DAA1286
fatty acid binding protein 4, adipocyte
Molecular
visual apparatus
Mouse
Fabp4
188.0% Increase Gene Expression Level
DAA1291
lectin, galactose binding, soluble 3
Molecular
visual apparatus
Mouse
Lgals3
141.0% Increase Gene Expression Level
DAA1289
integrin beta 2
Molecular
visual apparatus
Mouse
Itgb2
306.0% Increase Gene Expression Level
DAA1284
serine (or cysteine) peptidase inhibitor, clade A, member 3N
Molecular
visual apparatus
Mouse
Serpina3n
141.0% Increase Gene Expression Level
DAA1285
cathepsin S
Molecular
visual apparatus
Mouse
Ctss
74.0% Increase Gene Expression Level
DAA1290
cathepsin K
Molecular
visual apparatus
Mouse
Ctsk
58.0% Increase Gene Expression Level
DAA1288
lysozyme 1
Molecular
visual apparatus
Mouse
Lyz1
82.0% Increase Gene Expression Level
DAA1067
transporter activity decreases
Molecular
blood brain barrier
Human
—
—
DAA1065
efflux pump activity decreases
Molecular
blood brain barrier
Human
—
—
DAA1066
glucose transporter 1 activity decreases
Molecular
blood brain barrier
Human
SLC2A1
—
DAA1967
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase
Molecular
cerebellum
Mouse
—
—
DAA1093
Prostaglandin E Receptor 3 (subtype EP3)
Molecular
cerebellum
Human
PTGER3
Increase DNA Methylation
DAA1105
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6
Molecular
cerebellum
Human
B3GALT6
Increase DNA Methylation
DAA1085
Rhomboid Domain Containing 1
Molecular
cerebellum
Human
RHBDD1
Increase DNA Methylation
DAA1109
Dickkopf-like 1
Molecular
cerebellum
Human
DKKL1
Increase DNA Methylation
DAA1964
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase
Molecular
cerebellum
Mouse
Alox5
—
DAA1113
Growth Arrest-specific 2 Like 3
Molecular
cerebellum
Human
GAS2L3
Increase DNA Methylation
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1283 | wingless related MMTV integration site 10a | Molecular | cochlea | Mouse | Wnt10a | 16.0% Increase Gene Expression Level | |
DAA1277 | aldo-keto reductase family 1, member C18 | Molecular | cochlea | Mouse | Akr1c18 | 20.0% Decrease Gene Expression Level | |
DAA1279 | phosphopantothenoylcysteine decarboxylase | Molecular | cochlea | Mouse | Ppcdc | 6.0% Increase Gene Expression Level | |
DAA1280 | oxytocin receptor | Molecular | cochlea | Mouse | Oxtr | 19.0% Increase Gene Expression Level | |
DAA1282 | deleted in malignant brain tumors 1 | Molecular | cochlea | Mouse | Dmbt1 | 1.0% Increase Gene Expression Level | |
DAA1281 | indolethylamine N-methyltransferase | Molecular | cochlea | Mouse | Inmt | 6.0% Decrease Gene Expression Level | |
DAA1278 | CD38 antigen | Molecular | cochlea | Mouse | Cd38 | 26.0% Increase Gene Expression Level | |
DAA1287 | fatty acid binding protein 5, epidermal | Molecular | visual apparatus | Mouse | Fabp5 | 259.0% Increase Gene Expression Level | |
DAA1286 | fatty acid binding protein 4, adipocyte | Molecular | visual apparatus | Mouse | Fabp4 | 188.0% Increase Gene Expression Level | |
DAA1291 | lectin, galactose binding, soluble 3 | Molecular | visual apparatus | Mouse | Lgals3 | 141.0% Increase Gene Expression Level | |
DAA1289 | integrin beta 2 | Molecular | visual apparatus | Mouse | Itgb2 | 306.0% Increase Gene Expression Level | |
DAA1284 | serine (or cysteine) peptidase inhibitor, clade A, member 3N | Molecular | visual apparatus | Mouse | Serpina3n | 141.0% Increase Gene Expression Level | |
DAA1285 | cathepsin S | Molecular | visual apparatus | Mouse | Ctss | 74.0% Increase Gene Expression Level | |
DAA1290 | cathepsin K | Molecular | visual apparatus | Mouse | Ctsk | 58.0% Increase Gene Expression Level | |
DAA1288 | lysozyme 1 | Molecular | visual apparatus | Mouse | Lyz1 | 82.0% Increase Gene Expression Level | |
DAA1067 | transporter activity decreases | Molecular | blood brain barrier | Human | — | — | |
DAA1065 | efflux pump activity decreases | Molecular | blood brain barrier | Human | — | — | |
DAA1066 | glucose transporter 1 activity decreases | Molecular | blood brain barrier | Human | SLC2A1 | — | |
DAA1967 | Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase | Molecular | cerebellum | Mouse | — | — | |
DAA1093 | Prostaglandin E Receptor 3 (subtype EP3) | Molecular | cerebellum | Human | PTGER3 | Increase DNA Methylation | |
DAA1105 | UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 | Molecular | cerebellum | Human | B3GALT6 | Increase DNA Methylation | |
DAA1085 | Rhomboid Domain Containing 1 | Molecular | cerebellum | Human | RHBDD1 | Increase DNA Methylation | |
DAA1109 | Dickkopf-like 1 | Molecular | cerebellum | Human | DKKL1 | Increase DNA Methylation | |
DAA1964 | Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase | Molecular | cerebellum | Mouse | Alox5 | — | |
DAA1113 | Growth Arrest-specific 2 Like 3 | Molecular | cerebellum | Human | GAS2L3 | Increase DNA Methylation |